Lasers in Veins? FDA Says Proceed with Caution
Published Date: 4/30/2026
Rule
Summary
The FDA is officially classifying the laser-powered inferior vena cava filter retrieval catheter as a Class II device, meaning it has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative medical tool faster and ensures it’s safe and effective. The new classification is effective April 30, 2026, and could save time and money for makers and users alike.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Detailed special-control testing and labeling rules
The final order lists specific special controls manufacturers must meet for Class II devices, including clinical performance testing (complication and success-rate evaluation), non-clinical performance testing (dimensional, mechanical, simulated use, fluoroscopic visibility, kink resistance), laser-generator compatibility and software testing, biocompatibility, sterility and shelf-life data, in vivo safety testing, labeling with technical and clinical summaries, and a training program.
Faster patient access to device
The FDA has classified the laser-powered IVC filter retrieval catheter as Class II, which the agency says will enhance patients' access to this device and reduce regulatory burdens. The final order is effective April 30, 2026, and the classification was applicable on December 21, 2021.
Enables easier future device approvals
Because the device was classified via the De Novo process, the laser-powered IVC filter retrieval catheter can serve as a predicate device for future products, allowing other sponsors to use the less burdensome 510(k) pathway instead of De Novo or premarket approval. This change may reduce time and regulatory burden for companies making similar devices.
Premarket 510(k) submission required
The order states that laser-powered IVC filter retrieval catheters are subject to premarket notification under section 510(k) of the FD&C Act, because FDA has not determined the device type should be exempt. Manufacturers must submit a 510(k) as the device is classified Class II.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He didn’t respond to the FDA’s warning, so the ban started on May 15, 2026. If he wants to end the ban early, he can apply anytime, but must follow special rules to keep his info private.
2026-09533 — Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
The FDA wants your help to improve tests that spot kidney damage caused by medicines. They’re asking researchers, doctors, and companies to share data by July 13, 2026, so they can make these kidney safety markers better and faster. This could lead to safer drugs and smarter health checks, benefiting patients and the medical community alike.
2026-09508 — Azodicarbonamide (ADA); Request for Information
The FDA is asking for info about azodicarbonamide (ADA), a chemical used in some foods and food packaging, to check if it’s still safe. Food makers, scientists, and anyone with data should share what they know by July 13, 2026. This review could lead to changes in how ADA is used, affecting food companies and possibly costs down the line.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This update affects drug makers and helps keep medicine safe by improving how side effects are tracked. You’ve got until July 13, 2026, to share your comments—no cost to join, just your voice!
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If renewed, the company can keep marketing them this way, with the comment period starting May 13, 2026.
2026-09507 — Butylated Hydroxytoluene (BHT); Request for Information
The FDA wants to know more about how butylated hydroxytoluene (BHT), a chemical used in food and food packaging, is being used and if it’s still safe. They’re asking companies, scientists, and the public to share any info by July 13, 2026. This could lead to changes in rules that affect food makers and might impact what’s allowed in your snacks and packaging.
Previous / Next Documents
Previous: 2026-08425 — Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System
The FDA is officially putting brain temperature measurement systems into Class II, meaning they’ll follow special safety rules but face fewer hurdles than before. This change helps make sure these devices are safe and effective while speeding up patient access to cool new tech. The new classification is effective April 30, 2026, but has been in effect since March 29, 2022, so manufacturers should be ready to follow the updated rules.
Next: 2026-08433 — Review of the Commission's Rules Governing the 896-901/935-940 MHz Band; Correction
The FCC fixed some small mistakes in its rules about the 896-901/935-940 MHz radio bands, which affect companies holding or applying for 900 MHz broadband licenses. These corrections clarify who qualifies for licenses and the coverage they must provide, with clear deadlines to meet service goals. The updated rules take effect April 30, 2026, helping license holders avoid confusion and stay on track without extra costs.